Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IMTX · NASDAQ · Biological Products, (No Diagnostic Substances) · Foreign private issuer
Immatics (IMTX) · oqro.io/stocks/IMTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$6.39−0.13 (−1.99%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Next results expected Mar 3, 2027, after the market closes (Q4 2026). Dates can move until the company confirms them.
No official announcements
No 8-K filed in the last 60 days.
Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.
